On January 15, 2025, the US Drug Enforcement Administration (DEA) released a proposed rule entitled Special Registrations for Telemedicine and

Rule will make permanent the temporary waivers easing access to buprenorphine via telehealth that began during the COVID-19 pandemic.

The new notice of proposed rulemaking adheres to calls from Congress and industry for the agency to create a special telemedicine registration system. Its three-tiered approach could cost telehealth companies over $40,

Long-term care providers who prescribe controlled substances via telehealth may soon be subject to a tiered federal registration system.

Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain controlled substances under a proposed rule issued Wednesday by the agency. "DEA's goal is to provide telehealth access for needed medications while ensuring patient safety and preventing the diversion of medications into the illicit drug market,

A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, contraindications.

“Basically, the farther the patients resided from an abortion facility, the more they were depending on the pills being mailed to them,” co-lead researcher Dr. Emily Godfrey, an OB/GYN and family doctor with the University of Washington, said in a news release.

The Food and Drug Administration released on Tuesday its long-awaited proposal to require food manufacturers to put some nutrition facts on the front of packages, in a bid to nudge Americans and ...

The distance between a patient’s home and an abortion-services facility where they would seek care significantly influences how they receive birth-control medications, according to a

The Biden administration has finalized a ... gold-standard opioid use disorder treatments through telehealth. The final rule from the Drug Enforcement Administration and the Substance Abuse ...

A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide. The states of Idaho, Kansas and Missouri can now move ahead with their efforts in U.

More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.